Osteopenia and Ejection fraction decreased

Summary:

Ejection fraction decreased is found among people with Osteopenia, especially for people who are 60+ old.

The study analyzes which people have Ejection fraction decreased with Osteopenia. It is created by eHealthMe based on reports of 53 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,435 drugs and 1,172 conditions by eHealthMe. Check the latest studies of Osteopenia.

What is Ejection fraction decreased?

Ejection fraction decreased (systolic heart failure) is found to be associated with 1,059 drugs and 1,256 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

53 people who have Osteopenia and Ejection Fraction Decreased are studied.

$Would you have Ejection fraction decreased when you have Osteopenia?$

Age of people who have Osteopenia and experienced Ejection Fraction Decreased *:

Common co-existing conditions for these people *:

Pain: 44 people, 83.02%
Pleural Effusion (water on the lungs): 43 people, 81.13%
Back Pain: 42 people, 79.25%
Dyspnea (difficult or laboured breathing): 42 people, 79.25%
Breast Cancer: 40 people, 75.47%
Urinary Tract Infection: 40 people, 75.47%
Breast Cancer Metastatic: 20 people, 37.74%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 15 people, 28.30%
Diarrhea: 11 people, 20.75%
Nausea (feeling of having an urge to vomit): 9 people, 16.98%

Common drugs taken by these people *:

Ondansetron: 45 people, 84.91%
Clopidogrel: 45 people, 84.91%
Tobradex: 43 people, 81.13%
Alendronic Acid: 39 people, 73.58%
Iopidine: 38 people, 71.70%
Acetaminophen: 30 people, 56.60%
Chlorpheniramine Maleate: 30 people, 56.60%
Dexamethasone: 30 people, 56.60%
Docetaxel: 30 people, 56.60%
Indapamide: 30 people, 56.60%

Common symptoms for these people *:

Diarrhea: 50 people, 94.34%
Presyncope: 46 people, 86.79%
Back Pain: 46 people, 86.79%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 45 people, 84.91%
Hair Loss: 45 people, 84.91%
Pleural Effusion (water on the lungs): 45 people, 84.91%
Weight Decreased: 45 people, 84.91%
Nausea (feeling of having an urge to vomit): 45 people, 84.91%
Constipation: 45 people, 84.91%
Fatigue (feeling of tiredness): 45 people, 84.91%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ejection fraction decreased?

- Check whether Ejection fraction decreased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ejection fraction decreased and Osteopenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.